CRIXIVAN®:: A potent inhibitor of HIV-1 protease in vivo

被引：0
|
作者：
Huff, JR [1 ]
Vacca, JP [1 ]
Dorsey, BD [1 ]
Emini, EA [1 ]
Condra, JH [1 ]
Schleif, WA [1 ]
Massari, FE [1 ]
Deutsch, PJ [1 ]
Chodakewitz, J [1 ]
Kuo, LC [1 ]
Chen, Z [1 ]
机构：
[1] Merck Res Labs, W Point, PA USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A23
引用
收藏
页码：A856 / A856
页数：1
相关论文
共 50 条
  • [21] Stereocontrolled synthesis and biological activity of two diastereoisomers of the potent HIV-1 protease inhibitor saquinavir
    Righi, Giuliana
    Ciambrone, Simona
    Bonini, Carlo
    Camparter, Pietro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (02) : 902 - 908
  • [22] Computational study of KNI-272, a potent inhibitor of HIV-1 protease: On the mechanism of preorganization
    David, L
    Luo, R
    Head, MS
    Gilson, MK
    JOURNAL OF PHYSICAL CHEMISTRY B, 1999, 103 (06): : 1031 - 1044
  • [23] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Fun, Axel
    van Maarseveen, Noortje M.
    Pokorna, Jana
    Maas, Renee E. M.
    Schipper, Pauline J.
    Konvalinka, Jan
    Nijhuis, Monique
    RETROVIROLOGY, 2011, 8
  • [24] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Axel Fun
    Noortje M van Maarseveen
    Jana Pokorná
    Renée EM Maas
    Pauline J Schipper
    Jan Konvalinka
    Monique Nijhuis
    Retrovirology, 8
  • [25] Acquisition of multi-PI (protease inhibitor) resistance in HIV-1 in vivo and in vitro
    Yusa, K
    Harada, S
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (32) : 4055 - 4064
  • [26] HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
    Rhee, Soo-Yon
    Taylor, Jonathan
    Fessel, W. Jeffrey
    Kaufman, David
    Towner, William
    Troia, Paolo
    Ruane, Peter
    Hellinger, James
    Shirvani, Vivian
    Zolopa, Andrew
    Shafer, Robert W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4253 - 4261
  • [27] Atazanavir: A novel azapeptide inhibitor of HIV-1 protease
    Wang, F
    Ross, J
    FORMULARY, 2003, 38 (12) : 691 - +
  • [28] Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
    Barragan, Patricia
    Podzamczer, Daniel
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2363 - 2375
  • [29] Development of Sharkavir: A Hypothetical Inhibitor for HIV-1 Protease
    Hunt, Matthew
    Abbas, Feza
    Abbas, Lyla
    Ghali, Mina
    Ghali, Helana
    Chabbra, Alesa
    Lavin, Emily
    Sikora, Arthur
    FASEB JOURNAL, 2020, 34
  • [30] Influence of inhibitor binding on HIV-1 protease dynamics
    Ringhofer, S
    Dutzler, R
    Kallen, J
    Andrew, P
    Visser, A
    Billich, A
    Scholz, D
    Gstach, H
    Steinhauser, O
    Schreiber, H
    Auer, M
    Kungl, A
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 65 : PA309 - PA309
12345